Unlock the complexities of medicines under additional monitoring with AIDIFY’s comprehensive e-learning course designed for regulatory professionals and pharmacovigilance experts, this course offers a deep dive into the principles, legislation, and key stakeholders involved in the monitoring of medicines under additional scrutiny.
Enhanced post-authorisation data collection is crucial for promptly identifying new safety signals and informing the safe and effective use of medicines in everyday medical practice. Through this course, you’ll gain a clear understanding of the black triangle system and the medicines included under additional monitoring, along with the main roles and responsibilities of key stakeholders in this process.
By attending this course, you will:
- Acquire knowledge of additional monitoring requirements.
- Understand the concept of the black triangle and its significance in medicines monitoring.
- Gain insights into the main principles governing the list of medicines under additional monitoring.
- Familiarize yourself with the current positions and recommendations of the European Commission, Heads of Medicine Agencies, and the European Medicines Agency regarding additional monitoring.
Course Highlights:
- Expertly crafted presentation by Subject Matter Expert to provide in-depth insights into the subject matter.
- Engaging modules filled with practical examples.
- Obtain a recognized certificate upon successful completion, showcasing your expertise in medicines under additional monitoring.
- Opportunity to interact and discuss course content with AIDIFY platform users.
Enroll now and embark on a journey that blends theoretical depth with practical insights, equipping you with the knowledge and skills necessary to navigate the complexities of medicines under additional monitoring. A brighter, safer future in pharmacovigilance awaits you on AIDIFY!
